- Home
- CETY vs NLSP Comparison
CETY vs NLSP Comparison
Compare CETY & NLSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CETY
- NLSP
- Stock Information
- Founded
- CETY 1993
- NLSP 2015
- Country
- CETY United States
- NLSP Switzerland
- Employees
- CETY N/A
- NLSP N/A
- Industry
- CETY Power Generation
- NLSP Biotechnology: Pharmaceutical Preparations
- Sector
- CETY Utilities
- NLSP Health Care
- Exchange
- CETY Nasdaq
- NLSP Nasdaq
- Market Cap
- CETY 14.7M
- NLSP 12.4M
- IPO Year
- CETY N/A
- NLSP 2021
- Fundamental
- Price
- CETY $0.24
- NLSP $2.63
- Analyst Decision
- CETY
- NLSP
- Analyst Count
- CETY 0
- NLSP 0
- Target Price
- CETY N/A
- NLSP N/A
- AVG Volume (30 Days)
- CETY 619.3K
- NLSP 164.1K
- Earning Date
- CETY 08-19-2025
- NLSP 10-17-2025
- Dividend Yield
- CETY N/A
- NLSP N/A
- EPS Growth
- CETY N/A
- NLSP N/A
- EPS
- CETY N/A
- NLSP N/A
- Revenue
- CETY $1,743,723.00
- NLSP N/A
- Revenue This Year
- CETY N/A
- NLSP N/A
- Revenue Next Year
- CETY N/A
- NLSP N/A
- P/E Ratio
- CETY N/A
- NLSP N/A
- Revenue Growth
- CETY N/A
- NLSP N/A
- 52 Week Low
- CETY $0.20
- NLSP $1.30
- 52 Week High
- CETY $1.27
- NLSP $7.44
- Technical
- Relative Strength Index (RSI)
- CETY 47.48
- NLSP 60.48
- Support Level
- CETY $0.23
- NLSP $2.35
- Resistance Level
- CETY $0.27
- NLSP $2.65
- Average True Range (ATR)
- CETY 0.02
- NLSP 0.21
- MACD
- CETY -0.00
- NLSP 0.07
- Stochastic Oscillator
- CETY 12.79
- NLSP 84.16
About CETY Clean Energy Technologies Inc.
Clean Energy Technologies Inc is clean energy and environmentally sustainable technologies company offering heat recovery solutions products. In addition, it also provides engineering and manufacturing solutions focused on other energy-efficient and environmentally sustainable technologies. The company's principal product is the Clean Cycle generator, offered by Heat Recovery Solutions. The company's engineering and manufacturing resources support its heat recovery solutions business. It has four segments: Clean Energy HRS & CETY Europe, CETY Renewables Waste to Energy Solutions, Engineering and Manufacturing Business and CETY HK. It serves various markets, including industrial, aerospace, military, instrumentation, and medical.
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.